Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Bergeron

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Drugs & Aging|August 8, 2015
A Pharmacist-Physician Intervention Model Using a Computerized Alert System to Reduce High-Risk Medication Use in Elderly InpatientsKarolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, et al.
Parkinsonism & Related Disorders|August 19, 2015
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine releaseMattia Volta, Stefano Cataldi, Dayne Beccano-Kelly, et al.
Elife|September 21, 2017
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceMattia Volta, Dayne A Beccano-Kelly, Sarah A Paschall, et al.
Human Molecular Genetics|October 26, 2014
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memoryDayne A Beccano-Kelly, Mattia Volta, Lise N Munsie, et al.
Melanoma Research|June 7, 2024
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft modelPrisca Bustamante, Jacqueline Coblentz, Christina Mastromonaco, et al.
Journal of Parkinson'S Disease|July 9, 2014
Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimagingMatthew D Walker, Mattia Volta, Stefano Cataldi, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Drugs & Aging|August 8, 2015
A Pharmacist-Physician Intervention Model Using a Computerized Alert System to Reduce High-Risk Medication Use in Elderly InpatientsKarolann Arvisais, Sabrina Bergeron-Wolff, Christine Bouffard, et al.
Parkinsonism & Related Disorders|August 19, 2015
Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine releaseMattia Volta, Stefano Cataldi, Dayne Beccano-Kelly, et al.
Elife|September 21, 2017
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceMattia Volta, Dayne A Beccano-Kelly, Sarah A Paschall, et al.
Human Molecular Genetics|October 26, 2014
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memoryDayne A Beccano-Kelly, Mattia Volta, Lise N Munsie, et al.
Melanoma Research|June 7, 2024
Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft modelPrisca Bustamante, Jacqueline Coblentz, Christina Mastromonaco, et al.
Journal of Parkinson'S Disease|July 9, 2014
Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimagingMatthew D Walker, Mattia Volta, Stefano Cataldi, et al.
Pageof 2